International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 182-184 doi: 10.5281/zenodo.16521520
Original Article
Trends of cervical cytology in symptomatic postmenopausal woman at tertiary care hospital
 ,
 ,
 ,
Published
July 28, 2025
Abstract

Aims and objective-Present study was conducted to evaluate the cervical cytomorphology in symptomatic postmenopausal woman with symptoms related to urogenital atrophy. Material and methods- A total of 62 postmenopausal women presented with symptoms related to urogenital atrophy and cervical smear has examined for adequacy, density of inflammation with numerical scoring, specific pathogens and predominant cell type were assessed in each smear and correlated with presenting symptoms and duration of menopause were included in the study. Result- Smears of all patients showed inflammation, varying in intensity, irrespective of the presenting symptoms with a high incidence of candidiasis (9%). cytological smears showed that all patients of the study group with evidence of inflammation and density ranged from 1+ to 4+. 04 smears showed features of bacterial vaginosis. Coccobacilli overgrowth was observed in 19 smears. Lactobacilli were present only in 13 smears. The predominant cell found was the intermediate cell in 42 cases. Conclusion- Cytology (Pap smear) in post menopause can be used to assess hormonal status, to screen for malignancy, pathogens in inflammation and also to monitor hormone replacement therapy.

 

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1104 Views
16 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved